AI-generated summary
The authors systematically reviewed studies of blue-blocking lenses, including spectacles and intraocular lenses, for preventing blue light-related eye disorders, age-related macular degeneration progression, eye fatigue and sleep effects. They report that clinical efficacy is often theoretical or based on laboratory or animal experiments. They conclude there is a lack of consistent evidence to support wider routine clinical use of these lenses.
- Who or what was studied
- Studies of blue-blocking spectacles and intraocular lenses relevant to eye fatigue, sleep quality and age-related macular degeneration
- Limits stated in the abstract
- The abstract states that much of the supporting evidence comes from laboratory or animal experiments and that consistent clinical evidence is lacking.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Systematic review, Age-related macular degeneration, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.